Acquisition Opportunity MIDI Group was acquired by Biolog, Inc. in January 2023, suggesting potential cross-sell of MIDI’s rapid microbial identification services and Sherlock software to Biolog’s existing customer base and product ecosystem.

Expanded Capabilities With ISO/IEC 17025:2005 certified labs and expertise in DNA sequencing, MALDI-TOF, FAME, biochemical testing, PLFA, fire debris analysis, and Omega-3 testing, there are opportunities to offer end-to-end microbial identification and analytical services to potential pharmaceutical, biotech, agricultural, environmental, and public health clients.

Veteran-Owned Advantage Being a small veteran-owned business can be leveraged in sales outreach to government agencies and veteran-focused programs that value this credential, potentially easing procurement or eligibility for certain contracts.

Digital Outreach Active web presence and multiple tech stack tools indicate readiness for targeted digital marketing and lead-generation campaigns; opportunities exist to expand inbound inquiries for rapid identification services and Sherlock software licenses.

Market Fit Revenue in the mid-range of tens of millions positions MIDI as a candidate for strategic partnerships or channel alliances with larger diagnostics, life sciences, or instrument providers seeking complementary microbial identification and PLFA analytics capabilities.